Timefolio Kbio Active ETF (KRX:463050)
South Korea · Delayed Price · Currency is KRW 11,000
-80 (-0.72%)
At close: Sep 23, 2026
KRX:463050 Holdings Information
KRX:463050 is an equity ETF with a total of 10 individual holdings. The top holdings are Celltrion stock at 9.55%, OliX Pharmaceuticals at 9.08%, ALTEOGEN at 8.30%, Hanmi Pharm. at 6.35%, and Hanall Biopharma at 5.96%.
Total Holdings
10
Top 10 Percentage
62.35%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
35.52
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | KRX: 068270 | Celltrion, Inc. | 9.55% |
| 2 | KOSDAQ: 226950 | OliX Pharmaceuticals, Inc | 9.08% |
| 3 | KOSDAQ: 196170 | ALTEOGEN Inc. | 8.30% |
| 4 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 6.35% |
| 5 | KRX: 009420 | Hanall Biopharma Co., Ltd. | 5.96% |
| 6 | KOSDAQ: 141080 | LigaChem Biosciences Inc. | 4.88% |
| 7 | KOSDAQ: 310210 | Voronoi, Inc. | 4.64% |
| 8 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 4.59% |
| 9 | 12894=V6.KQ | HanmiPharm Future Oct 26 | 4.54% |
| 10 | KOSDAQ: 068760 | Celltrion Pharm, Inc. | 4.45% |
As of Sep 21, 2026